Delivery Order SPE2DB22D1002-SPE2DB25FLJC6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Itraconazole 10 mg/ml solution in 150 ml quantities, with a ceiling value of $1,538.96. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-competitive, non-set-aside contract action under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Itraconazole 10 mg/ml solution in a 150 ml quantity, with a ceiling value of $10,858.92. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Itraconazole 100 mg capsules in quantities of 30 units at a firm fixed price of $1,081.51. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the supply of ITRACONAZOLE 10 MG/ML SOLUTION 150ML, a pharmaceutical product. The award has a total ceiling value of $11,761.16 and an ultimate completion date of September 17, 2024. This contract is not associated with a set-aside program. As one of the largest pharmaceutical distributors in the United States, AmerisourceBergen holds several...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, valued at $3,634.86, represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle through December 2026. AmerisourceBergen, a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $16,602.00 to AmerisourceBergen Drug Corp on September 1, 2025, with completion targeted for September 2, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under the company's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $35,623.20 to AmerisourceBergen Drug Corp on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $12,188.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded contract executed by the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,963.79 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The delivery order carries no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $1,060.80 to AmerisourceBergen Drug Corp on May 12, 2025, with an ultimate completion date of May 13, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX). The order is to be performed at the contractor's corporate office location in Conshohocken,...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLJC6Delivery Order
The Defense Logistics Agency awarded a $1,923.70 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Itraconazole 10 mg/mL solution in a 150 mL quantity. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 25, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, the company demonstrates significant capability in fulfilling federal medical supply requirements through competitive procurement. The company also holds the potential to serve under the DLA Troop Support's planned Pharmaceutical Prime Vendor Global Program Generation V contracts, which are expected to make multiple awards across separate regions involving at least three different contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/24/25 |